[go: up one dir, main page]

WO2016122198A1 - Procédé pour résoudre le problème d'une détection d'acide nucléique dû au cycle seuil (ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à anp - Google Patents

Procédé pour résoudre le problème d'une détection d'acide nucléique dû au cycle seuil (ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à anp Download PDF

Info

Publication number
WO2016122198A1
WO2016122198A1 PCT/KR2016/000842 KR2016000842W WO2016122198A1 WO 2016122198 A1 WO2016122198 A1 WO 2016122198A1 KR 2016000842 W KR2016000842 W KR 2016000842W WO 2016122198 A1 WO2016122198 A1 WO 2016122198A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
target nucleic
pna probe
curve analysis
quencher
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/000842
Other languages
English (en)
Korean (ko)
Inventor
박재신
박희경
정진욱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seasunbio Materials Inc
Original Assignee
Seasunbio Materials Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020160009512A external-priority patent/KR101845043B1/ko
Application filed by Seasunbio Materials Inc filed Critical Seasunbio Materials Inc
Publication of WO2016122198A1 publication Critical patent/WO2016122198A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Definitions

  • the present invention relates to a method for solving the problem of nucleic acid detection according to the critical cycle (Ct) of the real-time polymerase chain reaction using a PNA probe, and more specifically, a reporter and a quencher for detecting a target nucleic acid ( Fusion curve analysis method using a PNA probe coupled to a quencher, a method for detecting and quantifying a target nucleic acid for solving a detection problem of a target nucleic acid according to a threshold cycle (Ct) using the same, a PNA probe using the method It relates to a kit for detecting and quantifying a target nucleic acid comprising a.
  • Ct critical cycle
  • Representative probes used in the real-time polymerase chain reaction are hydrolysis probes, which are prepared by complementary base sequences for a specific gene (specific sequence) to be analyzed and include the genes. Used for amplification and fusion analysis of sequences.
  • TaqMan probe structurally has a structure in which a fluorescent (fluorescent) at the 5 'end, and a quencher at the 3' end is coupled, and the probe is subjected to an annealing step during a polymerase chain reaction (PCR) process.
  • PCR polymerase chain reaction
  • hybridization to the complementary DNA sequence hybridize
  • the development of fluorescence is suppressed by the quencher.
  • the 5 'end of fluorescence is cut off by the activity of the 5' exonuclease of Taq DNA polymerase, which results in color development.
  • the technique applying the real-time polymerase chain reaction using the hydrolysis-type probe is used for reading such as disease diagnosis and individual identification. If the reading is incorrect, it may threaten human life and cause economic loss. Accurate and fast reading is required.
  • target genes to be used for the above-described methods of diagnosis and identification of individuals analysis is performed in single or mixed individuals.
  • the quantitative detection of the target gene as described above is a result of the threshold cycle (Ct) value using a commercially available hydrolysis probe, which causes a lot of confusion during reading.
  • the target gene is detected based on a fixed Ct value. Read whether it is (Stephen A.
  • the amount of PCR amplification product can be detected by fluorescence signal.
  • Intercalating method using an intercalator that binds to double-stranded DNA as a detection method, and uses an oligonucleotide labeled with a fluorescent substance at the 5 'end and a quencher at the 3' end. How to do it.
  • the intensity of the fluorescence signal increases with increasing amount of polynucleotides as the Real-Time PCR progresses, and the user generates an amplification profile curve indicating the intensity of the fluorescence signal according to the number of amplification cycles. You get
  • Amplification profile curves generally include a baseline region where the fluorescence signal of the background does not reflect the actual amount of polynucleotides, an exponential region where the fluorescence signal increases with the increase in the amount of polynucleotide products, and PCR. When the reaction reaches saturation, it is divided into a plateau region where no increase in fluorescence signal intensity is observed. The baseline region appears early in the PCR reaction because the amount of PCR amplification products has not yet reached a detectable amount.
  • the intensity of the fluorescence signal when the point of transition from the baseline region to the exponential region, that is, when the amount of PCR amplification products reaches a detectable amount by fluorescence is called a threshold and corresponds to a threshold in the amplification profile curve.
  • the number of amplification cycles is called the threshold cycle (Ct) value.
  • the log value of the initial polynucleotide amount and the threshold cycle value are in inversely strong relations, and typically the desired polynucleotide quantification is performed using the threshold cycle value.
  • Polynucleotide quantification using real-time polymerase chain reaction has large absolute and relative quantification.
  • Absolute quantification is a method of quantitating a standard curve of critical cycle values for a polynucleotide amount by performing a real-time polymerase chain reaction with a sample having a known polynucleotide amount. This method compares the relative amount with other samples even if the nucleotide amount is not known.
  • standard curves may or may not be used. In all these cases, in order to quantify, the threshold value must first be determined to calculate the threshold cycle value.
  • the number of cells in a reliable sample of a general real-time polymerase chain reaction is about 10 2 to 10 3 . If the quantitative value of the target gene in the mixed population is less than the number of reliable cells, it will have a higher Ct value than the DNA sample with the large amount of the target gene. However, the method of determining the result through the Ct value ignores fluorescence signals below the Ct value in most cases, even though the actual target gene exists because of the quantitative limitation of the target gene. For example, the identification of microorganisms that cause disease in the blood in emergency patients is a very high risk factor and incurs time costs for further verification.
  • PNA Peptide Nucleic Acid
  • the PNA probe hybridizes in the presence of complementary gene sequences, regardless of the activity of the 5 'exonuclease of Taq DNA polymerase. Is to send.
  • the PNA probe like the TaqMan probe, may detect a target gene through an additional melting step (melting step) after the amplification is completed, including a signal during the nucleic acid amplification process.
  • the additional amplification step can solve the shortcomings of the determination method using most of the Ct value.
  • the present inventors minimize the discrimination error of the presence of the target nucleic acid due to the false positive and false negative signals according to the critical cycle (Ct) value shown in the existing Real-Time PCR process, and the target nucleic acid.
  • Ct critical cycle
  • An object of the present invention is to minimize the detection error of a target nucleic acid by false positive and false negative signals according to the threshold cycle (Ct) value shown in Real-Time PCR, and to detect a target nucleic acid. Or to provide a target nucleic acid fusion curve analysis method using a PNA probe combined with a reporter (quenching) and a reporter (quenching) to quantify, the kit for the detection or quantification of the target nucleic acid through the melting curve analysis.
  • Ct threshold cycle
  • the present invention is (a) adding a sample suspected to contain the target nucleic acid and a PNA probe and TaqMan probe to which the nucleic acid polymerase, primer, reporter and quencher are bound, hybridize, and then asymmetric polymerization Amplifying using an asymmetric polymerase chain reaction; (b) melting the hybridized product with varying temperature to obtain a melting curve; And (c) analyzing the obtained fusion curves to detect or quantify the target nucleic acid, thereby solving the problem of detecting the target nucleic acid according to the threshold cycle (Ct) of the real-time polymerase chain reaction.
  • a method for detecting or quantifying target nucleic acid through target nucleic acid fusion curve analysis using a PNA probe in which a reporter and a quencher are combined is provided.
  • the present invention also provides a kit for detecting or quantifying target nucleic acid by using a target nucleic acid fusion curve analysis using the above method and including a reporter and a quencher-coupled PNA probe.
  • the present invention also relates to (a) adding a sample suspected of containing a target nucleic acid and a nucleic acid polymerase, a primer and a TaqMan probe, hybridizing and amplifying using an asymmetric polymerase chain reaction. step; (b) adding and hybridizing the probe with the reporter and quencher to the amplification product; (c) melting the hybridized product of step (b) while varying the temperature to obtain a melting curve; And (d) analyzing the obtained fusion curves to solve the problem of detecting target nucleic acids according to a threshold cycle (Ct) of a real-time polymerase chain reaction, comprising detecting or quantifying target nucleic acids.
  • a threshold cycle (Ct) of a real-time polymerase chain reaction comprising detecting or quantifying target nucleic acids.
  • the present invention also provides a kit for detecting or quantifying target nucleic acid by using a target nucleic acid fusion curve analysis using the above method and including a reporter and a quencher-coupled PNA probe.
  • 1 is a schematic diagram showing an improved detection method of a target nucleic acid according to Ct value using a PNA probe.
  • Figure 2 shows the amplification curve and melting curve temperature conditions for confirming the detection of the target nucleic acid according to the Ct value.
  • Figure 3 compares the amplification curves according to symmetric or asymmetric gene amplification of real-time polymerase chain reaction to read the results in Ct value.
  • Figure 6 shows the peak of the melting curve using the PNA probe.
  • FIG. 7 shows an amplification curve for identifying low concentration of nonspecific amplification products using PNA probe.
  • Figure 8 shows the melting curve peaks for distinguishing actual target nucleic acids from low concentrations of nonspecific amplification products.
  • the amplification curve and the melting curve were analyzed to solve the problem of detecting the target nucleic acid according to the Ct value by mixing the artificial synthetic oligo and PNA probe.
  • WSD White Spot
  • a target nucleic acid in order to minimize the error of discrimination of the presence or absence of a target nucleic acid by false positive and false negative signals, which is a problem of nucleic acid detection according to the threshold cycle (Ct), and to effectively detect the target nucleic acid.
  • Ct threshold cycle
  • Synthetic oligo was used, and primers and probes (hydrolysis probe and PNA probe) for amplifying the nucleic acid were used.
  • the actual starting point of the asymmetric and symmetric gene amplification corresponds to 25 cycles, but slightly less than the set Ct and relative fluorescence units (RFU) value to confirm the presence of the nucleic acid It was difficult to judge the existence. Difficulty in determining the presence or absence of the target nucleic acid identified above, as shown in Figure 4, through the fusion step of the asymmetric gene amplification product was able to clearly distinguish the authenticity of the result.
  • REU relative fluorescence units
  • the present invention provides a method for preparing a hybrid target comprising: (a) adding a PNA probe and a TaqMan probe to which a sample suspected of containing a target nucleic acid and a nucleic acid polymerase, a primer, a reporter, and a quencher are bound, hybridized, and then asymmetric polymerase. Amplifying using an asymmetric polymerase chain reaction; (b) melting the hybridized product with varying temperature to obtain a melting curve; And (c) analyzing the obtained fusion curves to detect or quantify the target nucleic acid, thereby solving the problem of detecting the target nucleic acid according to the threshold cycle (Ct) of the real-time polymerase chain reaction.
  • Ct threshold cycle
  • the present invention relates to a kit for detecting or quantifying target nucleic acid through target nucleic acid fusion curve analysis using a PNA probe.
  • an amplification cycle in which the intensity of a fluorescence signal when the amount of PCR amplification products reaches a fluorescence detectable amount is called a threshold and corresponds to a threshold in an amplification profile curve.
  • the number of times is called the threshold cycle (Ct) value.
  • Ct threshold cycle
  • the log value of the initial polynucleotide amount and the threshold cycle value are in inversely strong relations, and typically the desired polynucleotide quantification is performed using the threshold cycle value.
  • solve the problem of detecting the target nucleic acid according to the threshold cycle (Ct) of real-time polymerase chain reaction is the critical cycle (Ct) appearing in the conventional real-time PCR (Real-Time PCR) process Means to minimize the error of discrimination of the presence of the target nucleic acid by false positive and false negative signal according to the value, and to effectively detect and quantify the target nucleic acid, but is not limited thereto.
  • sample includes various samples, and preferably, a biosample is analyzed using the method of the present invention.
  • Biosamples of plant, animal, human, fungus, bacterial and viral origin can be analyzed.
  • the sample may be derived from a specific tissue or organ.
  • Representative examples of tissues include connective, skin, muscle or nerve tissue.
  • Representative examples of organs include eyes, brain, lungs, liver, spleen, bone marrow, thymus, heart, lymph, blood, bone, cartilage, pancreas, kidney, gallbladder, stomach, small intestine, testes, ovaries, uterus, rectum, nervous system, Glands and internal vessels are included.
  • the biosample to be analyzed includes any cell, tissue, fluid from a biological source, or any other medium that can be well analyzed by the present invention, which is the consumption of humans, animals, humans or animals. Samples obtained from food prepared for use are included.
  • the biological sample to be analyzed includes a bodily fluid sample, which includes blood, serum, plasma, lymph, breast milk, urine, feces, ocular fluid, saliva, semen, brain extracts (e.g., brain grinds), spinal fluid, appendix, spleen And tonsil tissue extracts, but is not limited thereto.
  • the PNA probe completely hybridizes with the base sequence of the target nucleic acid (perfect match) to show the expected melting temperature (Tm) value, and incomplete hybridization (mismatch) with the target nucleic acid having a base sequence difference It may be characterized by showing a lower melting temperature (Tm) value than expected.
  • the reporter is FAM (6-carboxyfluorescein), Texas red, HEX (2 ', 4', 5 ', 7', -tetrachloro-6-carboxy-4,7-dichlorofluorescein), JOE, CY3 and It may be characterized in that at least one selected from the group consisting of CY5, the quencher may be characterized in that at least one selected from the group consisting of TAMRA (6-carboxytetramethyl-rhodamine), BHQ1, BHQ2 and Dabcyl. have.
  • the false-positive and false-negative signals can be distinguished using the difference in the melting curve according to the target nucleic acid sequence
  • the PNA probe further comprises a locked nucleic acid (LNA) It can be characterized.
  • LNA locked nucleic acid
  • Locked nucleic acid that can be contained in the PNA probe in the present invention is a modified RNA nucleotide, modified in the form of combining the 2 'oxygen atoms and 4' carbon atoms of the ribose moiety (ribose moiety) It is.
  • LNAs can form oligonucleotides in a mixed form with DNA or RNA, and the locked ribose conformation of the blocked nucleic acids allows stacking between bases and pre-organization of the backbone. enhances the hybridization performance of oligonucleotides by promoting -organization.
  • Oligonucleotides used in molecular biological assays such as DNA microarrays, FISH probes, and Quantitative PCR (Q-PCR) probes, use LNA nucleotides to increase sensitivity and specificity.
  • nucleotides containing LNA are easy to detect short-length RNA or DNA targets, and have high resistance to nucleases, and thus are easy to use in vivo / in vitro .
  • 'Target nucleic acid' or 'synthetic oligo' of the present invention means a nucleic acid sequence to be detected or not, and includes a specific site of the nucleic acid sequence of the 'target gene' encoding a protein having physiological and biochemical functions. , Annealed or hybridized with primers or probes under hybridization, annealing or amplification conditions.
  • Hybridization' of the present invention is meant that complementary single stranded nucleic acids form a double-stranded nucleic acid.
  • Hybridization can occur when the complementarity between two nucleic acid strands is perfect or even when some mismatch base is present.
  • the degree of complementarity required for hybridization may vary depending on the hybridization conditions, and may be particularly controlled by temperature.
  • the PNA probe including the reporter and the quencher of the present invention hybridizes with the target nucleic acid and generates a fluorescence signal. As the temperature increases, the PNA probe rapidly melts with the target artificial oligo oligomer at an appropriate melting temperature of the probe, thereby extinguishing the fluorescent signal. The presence or absence of base denaturation of the target synthetic oligo may be detected through high resolution fluorescence melting curve analysis (FMCA) obtained from the fluorescence signal according to the temperature change.
  • FMCA fluorescence melting curve analysis
  • the probe of the present invention may combine a reporter and a fluorescent material of a quencher capable of quenching reporter fluorescence at both ends.
  • the reporter is reported as FAM (6-carboxyfluorescein), Texas red, HEX (2 ', 4', 5 ', 7', -tetrachloro-6-carboxy-4,7-dichlorofluorescein), JOE, CY3 and CY5.
  • the quencher may be one or more selected from the group consisting of TAMRA (6-carboxytetramethyl-rhodamine), BHQ1, BHQ2 and Dabcyl, but is not limited thereto, preferably Dabcyl You can use (FAM-labeled).
  • kits of the present invention may optionally include reagents necessary to conduct target nucleic acid amplification reactions (eg, PCR reactions) such as buffers, DNA polymerase cofactors and deoxyribonucleotide-5-triphosphates.
  • reagents necessary to conduct target nucleic acid amplification reactions eg, PCR reactions
  • the kits of the present invention may also include various polynucleotide molecules, reverse transcriptases, various buffers and reagents, and antibodies that inhibit DNA polymerase activity.
  • the optimum amount of reagent used in a particular reaction of the kit can be easily determined by those skilled in the art having learned the disclosure herein.
  • kits of the present invention can be made in a separate package or compartment containing the aforementioned components.
  • the synthetic oligo oligonucleotide and the PNA probe were separated to analyze the amplification curve and the melting curve for solving the detection problem of the target nucleic acid according to the Ct value.
  • WSD white spot disease
  • target nucleic acids were amplified symmetrically and asymmetrically using a PNA probe suitable for high temperature.
  • the amplification curve was difficult to distinguish the presence or absence of the nucleic acid according to the set Ct Cutoff value. Therefore, an additional PNA probe was added to the amplification product and a fusion step was performed to determine the authenticity of the correct target nucleic acid.
  • FIG 6 when the target nucleic acid was added it was confirmed whether the detection by showing the peak of the melting on the melting curve.
  • a method of distinguishing an amplification product of a real target nucleic acid from a low concentration of nonspecific amplification product using a PNA probe was made.
  • the positive control when identifying the amplification curve using PROBE-3 (PNA probe) When the target nucleic acid of 0.01 ng was used, the Ct value was 36 when the RFU (light intensity or the concentration of the product of the amplified target nucleic acid) was 1000, but the Ct value was used when the low concentration of the target nucleic acid (0.001 ng / sample) was used.
  • the low concentrations of the target nucleic acid and negative control showed a slight amplification curve.
  • the dissolution curve analysis was performed using PROBE-4 (PNA probe), as shown in Figure 8, in the melting curve analysis 0.01ng target nucleic acid
  • Tm intrinsic temperature
  • the concentration of the minimum amplification product is required to confirm whether the amplification product is the actual target nucleic acid amplification product or the nonspecific amplification product at the intrinsic temperature using the PNA probe.
  • the present invention provides a method for preparing an asymmetric polymerase chain reaction, comprising: (a) adding a sample suspected of containing a target nucleic acid, a nucleic acid polymerase, a primer, and a TaqMan probe, hybridizing, and then performing an asymmetric polymerase chain reaction.
  • the present invention relates to a kit for detecting or quantifying a target nucleic acid by analyzing a target nucleic acid fusion curve including a PNA probe.
  • the PNA probe completely hybridizes with the base sequence of the target nucleic acid (perfect match) to show the expected melting temperature (Tm) value, and incomplete hybridization (mismatch) with the target nucleic acid having a base sequence difference It may be characterized by showing a lower melting temperature (Tm) value than expected.
  • the reporter is FAM (6-carboxyfluorescein), Texas red, HEX (2 ', 4', 5 ', 7', -tetrachloro-6-carboxy-4,7-dichlorofluorescein), JOE, CY3 and It may be characterized in that at least one selected from the group consisting of CY5, the quencher may be characterized in that at least one selected from the group consisting of TAMRA (6-carboxytetramethyl-rhodamine), BHQ1, BHQ2 and Dabcyl. have.
  • the false-positive and false-negative signals can be distinguished using the difference in the melting curve according to the target nucleic acid sequence
  • the PNA probe further comprises a locked nucleic acid (LNA) It can be characterized.
  • LNA locked nucleic acid
  • the WSD artificial oligo oligonucleotide was used, and primers and probes (hydrolysis probe and PNA probe) for amplifying the nucleic acid were prepared and used based on the nucleotide sequence shown in the OIE standard.
  • the PNA probe used in the present invention may be prepared to additionally contain locked nucleic acid (LNA).
  • Contained nucleic acids are modified RNA nucleotides that are modified in the form of a combination of 2 'oxygen atoms and 4' carbon atoms of a ribose moiety.
  • LNAs can form probes (oligonucleotides) in mixed form with DNA or RNA, and the locked ribose conformation of blocked nucleic acids allows stacking between bases and pre-backing of backbones. Promoting pre-organization increases the hybridization performance of the probe.
  • an artificial synthetic oligo having an OIE primer sequence but having one base sequence complementary to the probe was prepared.
  • Complementary artificial synthetic oligos capable of confirming abnormalities of the PNA probe were prepared and used (see Table 1; O in Table 1 represents a linker and K represents lysine).
  • All PNA probes (FAM-labeled, Dabcyl) used in the present invention were synthesized by HPLC purification method in Panagene (Panagene, Korea), and the purity of all synthesized probes was confirmed by mass spectrometry, and further compared with the target nucleic acid. Unnecessary secondary structures of the probes were avoided for effective binding. In addition, in order to avoid crossing with the fluorescent probes marked on the OIE, fluorescence of different wavelengths was produced.
  • PCR Polymerase Chain Reaction
  • Table 1 below shows probes and oligo sequences for the detection of artificial synthetic oligos.
  • Example 2 Analysis method of amplification curve and melting curve for solving Ct value by mixing artificial synthetic oligo and PNA probe
  • the conditions for the analysis of the amplification curve and the melting curve for minimizing the discrimination error of the presence of the target nucleic acid by false-positive and false-negative signals, the detection problems of the target nucleic acid according to the Ct value, and the effective detection of the target nucleic acid were as follows.
  • the reaction was performed 40 times for 2 minutes at 50 ° C, 10 minutes at 95 ° C, 15 seconds at 95 ° C, and 1 minute at 60 ° C.
  • the process for the calcite is performed in a denaturation step of 3 minutes at 90 ° C., 1 minute at 75 ° C., and 1 minute at 55 ° C., followed by melting curve analysis to measure fluorescence by increasing the temperature from 20 ° C. to 90 ° C. in 0.5 ° C. steps. It was. It was kept stationary for 5 seconds between each step ( Figure 2).
  • the amplification curve and the melting curve analysis were performed by varying the concentration of the sample.
  • Non-specific amplification that can occur by real-time polymerase chain reaction using NTC-1 artificial oligos that are not affected by gene amplification and artificially amplified by actual samples containing target nucleic acid. band)) and below the Ct value (cycle to determine that no target nucleic acid is present).
  • the Ct value was set to 30 and the RFU (relative fluorescence units; light intensity) was set to cutoff, and the target nucleic acid was not present when the cycle was 30 or more and less than RFU 1000.
  • RFU relative fluorescence units; light intensity
  • the starting point of the actual asymmetric and symmetric gene amplification corresponds to 25 cycles, but it was difficult to determine the presence of the target nucleic acid to the extent that it is slightly below the set Ct value and RFU value to confirm the presence of the nucleic acid of the actual sample.
  • the blue line of FIG. 3 is an actual sample containing a target nucleic acid, and the red line corresponds to a negative control group (D.W). This result is seen in most real-time polymerase reactors that determine the presence or absence of a target nucleic acid by Ct value. Difficulty in determining the presence or absence of the target nucleic acid identified above, as shown in Figure 4, through the fusion step of the asymmetric gene amplification product was able to clearly distinguish the authenticity of the result.
  • Example 3 Analysis method of amplification curve and melting curve for solving Ct value by separating artificial synthetic oligo and PNA probe
  • Experimental conditions for determining the WSD of the OIE regulations should be amplified target symmetrically using a primer for amplifying the target nucleic acid.
  • a primer for amplifying the target nucleic acid In order to analyze the melting curve using the PNA probe, it is necessary to amplify the target nucleic acid asymmetrically (Asymmetric).
  • a PNA probe suitable for high temperature was manufactured.
  • Target nucleic acid amplification according to OIE criteria is performed by using a hydrolysis probe only, and when a result of the amplification curve of Ct value or non-specific band (non-specific band) is generated, the PNA probe is additionally added. It is attached and confirmed. In this manner, the target nucleic acid was single-stranded to a high temperature while complying with the OIE standard, and then the experiment was performed to bind the PNA probe.
  • the reaction was performed 40 times for 2 minutes at 50 ° C, 10 minutes at 95 ° C, 15 seconds at 95 ° C, and 1 minute at 60 ° C.
  • the amplification curve was difficult to distinguish the presence or absence of the nucleic acid according to the set Ct Cut off value.
  • the blue line of Fig. 5 is a sample containing the actual target nucleic acid, and the red line corresponds to the negative control group (DW), if the Ct value is 30 or more and the RFU value is 1000 or less, it is assumed that the target nucleic acid is substantially present. In the case of the above experiment, it may be difficult to determine the result, or it may be determined that the target nucleic acid does not exist.
  • the addition of the PNA probe to the amplification product may further determine the authenticity of the target nucleic acid.
  • a general target nucleic acid can be identified by preparing a PNA probe having a binding force at a temperature higher than a denatured temperature (about 75 ° C. or more).
  • the experimental conditions for the melting curve analysis using the PNA probe were as follows; 25 [mu] l of the amplification product used for amplification curve analysis and 0.5 [mu] l (10 pmol) of PROBE-2 (SEQ ID NO: 2) were added.
  • the reaction was performed 40 times for 2 minutes at 50 ° C, 10 minutes at 95 ° C, 15 seconds at 95 ° C, and 1 minute at 60 ° C.
  • the process for the calcite is performed in a denaturation step of 3 minutes at 90 ° C., 1 minute at 75 ° C., and 1 minute at 55 ° C., followed by melting curve analysis to measure fluorescence by increasing the temperature from 20 ° C. to 90 ° C. in 0.5 ° C. steps. It was.
  • the suspension was held for 5 seconds between each step.
  • the blue line of FIG. 6 is an amplification product of a sample containing a target nucleic acid
  • the red line is a negative control (D.W).
  • PROBE-3 SEQ ID NO: 3
  • PROBE-4 SEQ ID NO: 4
  • the experimental method is as follows; 2X TaqMan Universal PCR Master Mix (PE Applied Biosystems, Foster City, CA, USA) 12.5 ⁇ l, PROBE-3 (SEQ ID NO: 3) (neoprov, Korea) 1.5 ⁇ l / 1 pmol, Primer-2 so that the total volume is 25 ⁇ l.
  • the reaction was performed 40 times for 2 minutes at 50 ° C, 10 minutes at 95 ° C, 15 seconds at 95 ° C, and 1 minute at 60 ° C.
  • the concentration of primers was added symmetrically, and experiments were performed using the method of Korean Patent Application No. (10-2013-0106692) as a method for increasing the binding force of the PNA probe.
  • the experimental method is as follows; Experiments were performed by adding 0.5 ⁇ l / unit of Lambda exonulease and 0.5 ⁇ l / 10 pmol of PROBE-4 (SEQ ID NO: 4) to 0.01 ng target nucleic acid, 0.001 ng target nucleic acid, or negative control, which were amplification products per sample, respectively.
  • the melting curve analysis using the PNA probe was first performed by removing the strand bound to the phosphate group at the 5 'end of the product generated through amplification to make a single strand.
  • the melting curve analysis was performed after 5 minutes at 95 ° C, 30 seconds at 75 ° C, and 30 seconds at 55 ° C, followed by melting curve analysis at 1 ° C from 45 ° C to 80 ° C. Was performed.
  • the PNA probe was used to identify an improved melting curve analysis method that can distinguish the authenticity of low concentration nonspecific amplification products.
  • the method for confirming the presence or absence of an amplification curve of a low concentration of nonspecific amplification products was the same as the amplification method used in FIG. 7.
  • the experimental method is as follows; 5 ⁇ l of target product amplified to a total volume of 20 ⁇ l, 10 ⁇ l of 2X qPCR PreMix (Eye Biomaterials, Korea), 0.5 ⁇ l / 10 pmol of PROBE-4 (SEQ ID NO: 4), Primer-1-R (SEQ ID NO: 7) (0.5 ⁇ l / 100 pmol) and 4 ⁇ l of sterilized distilled water were added.
  • the target nucleic acid in the experiment was 0.01 ng (positive control) and 0.001 ng (low concentration of target nucleic acid) per sample, and distilled water was used as a negative control.
  • the process for melting curve analysis was performed 15 minutes at 95 ° C. for 5 minutes, 95 ° C. for 3 seconds, and 56 ° C. for 30 seconds, at 76 ° C. for 30 seconds, for 5 minutes at 95 ° C., at 75 ° C. for 30 seconds, and at 55 ° C.
  • the melting curve analysis to measure the fluorescence was carried out in 1 °C increments from 45 °C to 80 °C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé pour résoudre le problème d'une détection d'acide nucléique dû à un cycle seuil (Ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à ANP et, plus particulièrement, un procédé d'analyse d'une courbe de fusion à l'aide d'une sonde à ANP à laquelle sont liés un rapporteur et un extincteur pour la détection d'un acide nucléique cible, un procédé pour détecter et quantifier un acide nucléique cible pour résoudre le problème de la détection de l'acide nucléique cible dû à un cycle seuil (Ct) l'utilisant et un kit pour détecter et quantifier un acide nucléique cible, à l'aide du procédé et comprenant une sonde à ANP. L'utilisation du procédé de détection et de quantification d'un acide nucléique cible à l'aide d'une sonde à ANP, à laquelle sont liés un rapporteur et un extincteur, selon la présente invention conduit à la résolution d'un problème technique provoqué par la réalisation de la détermination sur base de la valeur du cycle seuil (Ct) de la réaction en chaîne par polymérase en temps réel, qui est utilisée dans le procédé pour le diagnostic et l'identification et l'analyse d'individus, ce qui permet d'améliorer la précision de la lecture du résultat de détection et de quantification d'un acide nucléique cible ou d'un gène cible et de réduire les coûts économiques, sociaux et médicaux.
PCT/KR2016/000842 2015-01-30 2016-01-27 Procédé pour résoudre le problème d'une détection d'acide nucléique dû au cycle seuil (ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à anp Ceased WO2016122198A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2015-0015214 2015-01-30
KR20150015214 2015-01-30
KR1020160009512A KR101845043B1 (ko) 2015-01-30 2016-01-26 PNA 프로브를 이용한 실시간 중합효소연쇄반응의 임계 사이클(Ct)에 따른 핵산 검출의 문제를 해결하는 방법
KR10-2016-0009512 2016-01-26

Publications (1)

Publication Number Publication Date
WO2016122198A1 true WO2016122198A1 (fr) 2016-08-04

Family

ID=56543738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/000842 Ceased WO2016122198A1 (fr) 2015-01-30 2016-01-27 Procédé pour résoudre le problème d'une détection d'acide nucléique dû au cycle seuil (ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à anp

Country Status (1)

Country Link
WO (1) WO2016122198A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112020000525B4 (de) * 2019-01-24 2025-02-06 Seasun Biomaterials Verfahren zum nachweis mehrerer ziele basierend auf einer einzigen nachweissonde unter verwendung eines markierungs-sequenz-snp

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100098570A (ko) * 2008-12-16 2010-09-07 아크레이 가부시키가이샤 핵산 증폭의 컨트롤의 검출 방법 및 그 용도
KR20140046688A (ko) * 2012-10-10 2014-04-21 주식회사 파나진 리포터 및 소광자가 결합된 pna 프로브를 이용한 융해곡선 분석방법, 융해곡선 분석을 통한 염기다형성 분석방법 및 염기다형성 분석 키트.
KR20140053945A (ko) * 2011-07-12 2014-05-08 주식회사 파나진 평행 결합 구조의 이중 혼성화 ｐｎａ 프로브 시스템
KR20140091944A (ko) * 2013-01-14 2014-07-23 주식회사 시선바이오머티리얼스 내부컨트롤 및 리포터 및 소광자가 결합된 pna 프로브를 이용한 용융곡선 분석방법, 이를 이용한 표적핵산 검출방법 및 표적핵산 검출 키트

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100098570A (ko) * 2008-12-16 2010-09-07 아크레이 가부시키가이샤 핵산 증폭의 컨트롤의 검출 방법 및 그 용도
KR20140053945A (ko) * 2011-07-12 2014-05-08 주식회사 파나진 평행 결합 구조의 이중 혼성화 ｐｎａ 프로브 시스템
KR20140046688A (ko) * 2012-10-10 2014-04-21 주식회사 파나진 리포터 및 소광자가 결합된 pna 프로브를 이용한 융해곡선 분석방법, 융해곡선 분석을 통한 염기다형성 분석방법 및 염기다형성 분석 키트.
KR20140091944A (ko) * 2013-01-14 2014-07-23 주식회사 시선바이오머티리얼스 내부컨트롤 및 리포터 및 소광자가 결합된 pna 프로브를 이용한 용융곡선 분석방법, 이를 이용한 표적핵산 검출방법 및 표적핵산 검출 키트

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OH ET AL.: "Detection of Low-level KRAS Mutations Using PNA-mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes", JOURNAL OF MOLECULAR DIAGNOSTICS, vol. 12, no. 4, 2010, pages 418 - 424 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112020000525B4 (de) * 2019-01-24 2025-02-06 Seasun Biomaterials Verfahren zum nachweis mehrerer ziele basierend auf einer einzigen nachweissonde unter verwendung eines markierungs-sequenz-snp

Similar Documents

Publication Publication Date Title
US11041190B2 (en) Genetic markers for discrimination and detection of red sea bream iridovirus causing infectious aquatic organism diseases, and method of discriminating and detecting the virus using the same
US6238866B1 (en) Detector for nucleic acid typing and methods of using the same
JP4481491B2 (ja) 核酸の検出方法
CN109837333B (zh) 同时检测多种目标基因的荧光实时检测试剂及方法
KR102338861B1 (ko) RT-LAMP를 이용한 코로나바이러스감염증-19을 일으키는 SARS-CoV-2의 검출용 PNA 프로브와 프라이머 및 이를 이용한 감염여부 판별방법
KR101642783B1 (ko) 참돔 이리도바이러스병 원인바이러스의 검출용 유전자 마커, 및 이를 이용한 원인바이러스의 검출 방법
US20220259664A1 (en) Combined auxiliary diagnostic method, kit, system and use of point mutation and methylation of bladder cancer driver genes
US20140017692A1 (en) Method and kit for detecting target nucleic acid
WO2017099445A1 (fr) Marqueur génétique permettant de distinguer et de détecter des bactéries à l'origine de l'infection à edwardsiella et de la streptococcocie chez le poisson, et procédé de différenciation et de détection de telles bactéries utilisant ledit marqueur
WO2020096394A1 (fr) Procédé, kit et dispositif d'acp pour la détection de méthylation d'un gène à l'aide d'une sonde de réduction
KR101782489B1 (ko) 바이러스성 출혈성 패혈증 바이러스의 검출용 pna 프로브 및 그 용도
WO2013122319A1 (fr) Procédé de détection de gène cible ou mutation associée utilisant une réaction de ligase et réaction d'amplification d'enzyme de coupure
WO2018092998A1 (fr) Procédé de détection de mutation génétique du virus de la septicémie hémorragique virale
KR101845043B1 (ko) PNA 프로브를 이용한 실시간 중합효소연쇄반응의 임계 사이클(Ct)에 따른 핵산 검출의 문제를 해결하는 방법
WO2016122198A1 (fr) Procédé pour résoudre le problème d'une détection d'acide nucléique dû au cycle seuil (ct) de la réaction en chaîne par polymérase en temps réel à l'aide d'une sonde à anp
EP4317455A1 (fr) Procédé d'amplification d'acide nucléique cible utilisant une sonde de guidage et sonde de serrage et composition pour amplifier un acide nucléique cible le comprenant
US8642264B2 (en) Method of quantifying target and reference nucleic acid
CN115976197A (zh) 基于CRISPR-Cas13快速检测痛风ABCG2 SNP基因型的试剂盒及方法
WO2012070788A9 (fr) Procédé et trousse pour la quantification d'acides nucléiques
WO2018048021A1 (fr) Procédé d'analyse d'un snp d'un adn mitochondrial avec une sonde pna et l'analyse d'une courbe de fusion
CN114645077A (zh) 一种检测受体样品中供体的存在或比例的方法和试剂盒
CN117305466B (zh) 一种能够识别单碱基甲基化状态的检测方法
WO2023121335A1 (fr) Composition pour la détection du syndrome ulcératif épizootique et procédé pour la détection du syndrome ulcératif épizootique
WO2022124823A1 (fr) Composition pour diagnostiquer une maladie de nécrose hépatopancréatique aiguë chez les crevettes
WO2024034796A1 (fr) Procédé qpcr pour la détection d'un variant par analyse simultanée de multiples cibles

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16743676

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16743676

Country of ref document: EP

Kind code of ref document: A1